The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Inspire Medical ( ($INSP) ) has released its Q4 earnings. Here is a breakdown of the information Inspire Medical presented to its investors.

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...